Finally, we investigated whether NF-κB-mediated transcriptional upregulation of miR-335-3p contributed to the inhibition of APJ, a downstream target of miR-335-3p, during the development of CNH-induced PAH. The gene discussed is NFKB1; the disease is pulmonary arterial hypertension.